Jazz Pharmaceuticals
Identifying, developing and commercializing meaningful products that address unmet medical needs.
HQ location
Dublin, Ireland
Founding location
Palo Alto, United States
Website
Launch date
Employees
Market cap
$6.5b
Enterprise value
$9.3b
Share price
$106.12 JAZZ
Company register number
399192
Recent deals
loading funding rounds…
Adams Street Partners(exited)
Lehman Brothers(exited)
Prospect Venture Partners(exited)
Golden Gate Capital(exited)
Versant Ventures(exited)
Thoma Cressey Equity Partners(exited)
EGS Healthcare Capital Partners(exited)
Beecken Petty O'Keefe & Company(exited)
Longitude Capital(exited)
Azur Pharma(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 31 % | 18 % | 5 % | 6 % | 4 % | 5 % | 6 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 22 % | 30 % | 32 % | 34 % | 20 % | 44 % | 44 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (11 %) | (6 %) | 11 % | 14 % | (11 %) | 13 % | 17 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 16 % | 16 % | 22 % | 22 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by Jazz Pharmaceuticals
Edit
ACQUISITION by Jazz Pharmaceuticals Mar 2025
ACQUISITION by Jazz Pharmaceuticals Feb 2021
ACQUISITION by Jazz Pharmaceuticals Dec 2013
ACQUISITION by Jazz Pharmaceuticals Apr 2012
ACQUISITION by Jazz Pharmaceuticals May 2016
ACQUISITION by Jazz Pharmaceuticals Jul 2019
ACQUISITION by Jazz Pharmaceuticals Aug 2019
